Assay of Neurodegenerative Biomarkers in Human Plasma of Patients with Parkinson’s Disease

Oct 13

Written By Magqu

Assay of Neurodegenerative Biomarkers in Human Plasma of Patients with Parkinson's Disease - Lin et al.

Assay of Neurodegenerative Biomarkers in Human Plasma of Patients with Parkinson's Disease

Authors: Wei-Che Lin¹, Pai-Yi Chiu^2,3, Ming-Jang Chiu^4-7, Chaur-Jong Hu^8-11, Pei-Ning Wang^12-14, Ta-Fu Chen⁴, Fu-Chi Yang¹⁵, Li-Kai Huang^8,9, Cheng-Hsien Lu¹⁶, Heui-Chun Liu¹⁷, Shieh-Yueh Yang^17*

Citation

Wei-Che Lin, Pai-Yi Chiu, Ming-Jang Chiu, Chaur-Jong Hu, Pei-Ning Wang, Ta-Fu Chen, Fu-Chi Yang, Li-Kai Huang, Cheng-Hsien Lu, Heui-Chun Liu, Shieh-Yueh Yang
Assay of Neurodegenerative Biomarkers in Human Plasma of Patients with Parkinson's Disease

Magqu

Assay of Neurodegenerative Biomarkers in Human Plasma of Patients with Parkinson’s Disease

Citation

Article Link

Exploring CSF biomarkers in amyotrophic lateral sclerosis: Highlighting thesignificance of TDP-43

Mediating role of obstructive sleep apnea in altering slow-wave activity and elevating Alzheimer’s disease risk: Pilot study from a northern Taiwan cohort